NDC Compounded Drug 72682-2230-3 Riboflavin; Niacinamide; Dexpanthenol; Pyridoxine; Thiamine Hydrochloride
Injection Intramuscular; Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Riboflavin; Niacinamide; Dexpanthenol; Pyridoxine; Thiamine Hydrochloride
NDC crossover of B-complex 30ml with NDC 72682-2230 a human compounded drug with other similar products matching the same substance name (Riboflavin; Niacinamide; Dexpanthenol; Pyridoxine; Thiamine Hydrochloride) and the same administration route (intramuscular; intravenous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
72682-2230-1 | B-complex 30ml | Thiamine Hcl 75mg/ml / Riboflavin 2mg/ml / Niacinamide 75mg/ml / Dexpanthenol 2 Mg/ml / Pyridoxine 2mg/ml 30ml | 30 mL in 1 VIAL | Injection | Intramuscular; Intravenous | Anazaohealth Corporation |
Frequently Asked Questions
What is the NDC number assigned to B-complex 30ml?
B-complex 30ml was assigned by its manufacturer with NDC product code 72682-2230. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for B-complex 30ml?
The NDC package code 72682-2230-3 was assigned to a 30 mL in 1 VIAL of riboflavin; niacinamide; dexpanthenol; pyridoxine; thiamine hydrochloride administered intramuscular; intravenous via injection.
Who manufactures this product?
B-complex 30ml is manufactured by an outsourced facility and labeled by Anazaohealth Corporation. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 1 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by AnazaoHealth Corporation with NDC product codes 72682-2230-1.